Rabbit Recombinant Monoclonal MAT2A antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat, Recombinant full length protein - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IP | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Tested |
Rat | Expected | Tested |
Recombinant full length protein - Human | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/30 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info 1/1000 | Notes - |
Species Mouse | Dilution info 1/1000 | Notes - |
Species Rat | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate.
MAT1A
AMS2, MATA2, MAT2A, S-adenosylmethionine synthase isoform type-2, AdoMet synthase 2, Methionine adenosyltransferase 2, Methionine adenosyltransferase II, MAT 2, MAT-II
Rabbit Recombinant Monoclonal MAT2A antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat, Recombinant full length protein - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
MAT1A and MAT2A are enzymes also known as methionine adenosyltransferase 1A and 2A which play a critical role in the synthesis of S-adenosylmethionine (SAMe). MAT1A has a molecular mass of about 42 kDa while MAT2A varies slightly due to post-translational modifications. These enzymes are mainly expressed in the liver and extrahepatic tissues respectively. MAT1A predominantly functions in the liver where it serves an essential part in maintaining normal liver metabolism.
Methionine adenosyltransferase 1A and 2A function to catalyze the transfer of an adenosyl group from ATP to methionine forming SAMe. This reaction is part of a critical metabolic process acting as a source of methyl groups for methylation reactions. MAT1A commonly works as part of a homotetrameric complex while MAT2A can form both dimers and tetramers. This flexibility in complex formation helps regulate the production of SAMe based on cellular demands linking it to vital biomolecules synthesis.
Methionine salvage pathways and polyamine biosynthesis include the significant involvement of MAT1A and MAT2A. These enzymes provide the necessary SAMe for the transmethylation and transsulfuration pathways connecting to other proteins such as GNMT and SAH hydrolase. The enzymes' activity influences the levels of important intermediates impacting these pathways and resulting metabolic outputs.
Abnormal expression or dysfunction of methionine adenosyltransferase 1A and 2A associates with liver cirrhosis and hepatocellular carcinoma. Alterations in the enzymes’ activity can disrupt normal SAMe levels affecting methylation reactions and subsequent gene expression patterns. Key proteins like cyclin-dependent kinase (CDK) also interact with these enzymes further linking them to cancer progression and outcomes.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Exposure times: Lane 1: 1 second; Lane 2: 2 seconds.
Blocking/Dilution buffer: 5% NFDM/TBST.
Human MAT1A recombinant protein contains aa1-395 with a His-Tag®. This recombinant protein was made in-house.
All lanes: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/20000 dilution
Lane 1: Human MAT1A recombinant protein at 0.01 µg
Lane 2: Human MAT2A recombinant protein at 0.01 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 44 kDa
Observed band size: 44 kDa, 75 kDa
Blocking/Dilution buffer: 5% NFDM/TBST.
Lane 1: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/1000 dilution
Lanes 2 - 3: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/5000 dilution
Lane 1: Human fetal liver tissue lysate at 10 µg
Lane 2: Mouse liver tissue lysate at 10 µg
Lane 3: Rat liver tissue lysate at 10 µg
Lane 1: Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Lanes 2 - 3: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 44 kDa
Observed band size: 44 kDa
Exposure time: 1s
Blocking/Dilution buffer: 5% NFDM/TBST.
Lanes 1 - 3: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/10000 dilution
Lanes 4 - 6: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/1000 dilution
Lane 1: Ramos (human Burkitt's lymphoma cell line) whole cell lysate at 10 µg
Lane 2: U937 (human histiocytic lymphoma cell line) whole cell lysate at 10 µg
Lane 3: HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 10 µg
Lane 4: Human fetal heart tissue lysate at 10 µg
Lane 5: Human fetal kidney tissue lysate at 10 µg
Lane 6: Human fetal spleen tissue lysate at 10 µg
Lanes 1 - 3: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Lanes 4 - 6: Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Developed using the ECL technique.
Predicted band size: 44 kDa
Observed band size: 44 kDa
Exposure time: 3s
Exposure times: Lane 1-2: 5 seconds; Lane 3-6: 3 seconds.
Blocking/Dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/1000 dilution
Lane 1: Mouse kidney tissue lysate at 10 µg
Lane 2: Mouse spleen tissue lysate at 10 µg
Lane 3: Rat brain tissue lysate at 10 µg
Lane 4: Rat kidney tissue lysate at 10 µg
Lane 5: C6 (rat glial tumor cell line) whole cell lysate at 10 µg
Lane 6: NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 44 kDa
Observed band size: 44 kDa
MAT2A was immunoprecipitated from 0.35 mg of Ramos (human Burkitt's lymphoma cell line) whole cell lysate with ab192846 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab192846 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366), was used for detection at 1/10000 dilution.
Lane 1: Ramos whole cell lysate 10 μg (Input).
Lane 2: ab192846 IP in Ramos whole cell lysate.
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab192846 in Ramos whole cell lysate.
Exposure time: 1 second.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
All lanes: Immunoprecipitation - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846)
Observed band size: 44 kDa
Blocking/Dilution buffer: 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID: 18695670 and PMID: 22879628).
All lanes: Western blot - Anti-MAT1A + MAT2A antibody [EPR19048] (ab192846) at 1/20000 dilution
Lane 1: Untreated HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 2: HepG2 (human liver hepatocellular carcinoma cell line) treated with 500 ng/ml Lipopolysaccharides for 4 hours, whole cell lysate at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 44 kDa
Observed band size: 44 kDa
Exposure time: 5s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com